- Home
- AGNC vs VRNA Comparison
AGNC vs VRNA Comparison
Compare AGNC & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- VRNA
- Stock Information
- Founded
- AGNC 2008
- VRNA 2005
- Country
- AGNC United States
- VRNA United Kingdom
- Employees
- AGNC N/A
- VRNA N/A
- Industry
- AGNC Real Estate Investment Trusts
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- AGNC Real Estate
- VRNA Health Care
- Exchange
- AGNC Nasdaq
- VRNA Nasdaq
- Market Cap
- AGNC 9.2B
- VRNA 8.3B
- IPO Year
- AGNC 2008
- VRNA 2017
- Fundamental
- Price
- AGNC $9.49
- VRNA $90.02
- Analyst Decision
- AGNC Buy
- VRNA Strong Buy
- Analyst Count
- AGNC 10
- VRNA 9
- Target Price
- AGNC $9.75
- VRNA $112.56
- AVG Volume (30 Days)
- AGNC 23.2M
- VRNA 1.2M
- Earning Date
- AGNC 07-21-2025
- VRNA 08-07-2025
- Dividend Yield
- AGNC 15.29%
- VRNA N/A
- EPS Growth
- AGNC N/A
- VRNA N/A
- EPS
- AGNC 0.40
- VRNA N/A
- Revenue
- AGNC $584,000,000.00
- VRNA $118,535,000.00
- Revenue This Year
- AGNC $39.36
- VRNA $891.79
- Revenue Next Year
- AGNC $22.20
- VRNA $78.94
- P/E Ratio
- AGNC $23.71
- VRNA N/A
- Revenue Growth
- AGNC N/A
- VRNA N/A
- 52 Week Low
- AGNC $7.85
- VRNA $14.86
- 52 Week High
- AGNC $10.85
- VRNA $99.01
- Technical
- Relative Strength Index (RSI)
- AGNC 61.80
- VRNA 55.59
- Support Level
- AGNC $9.08
- VRNA $92.88
- Resistance Level
- AGNC $9.37
- VRNA $97.44
- Average True Range (ATR)
- AGNC 0.15
- VRNA 3.34
- MACD
- AGNC 0.01
- VRNA -1.05
- Stochastic Oscillator
- AGNC 94.69
- VRNA 9.89
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.